Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10738036 Deuterated CFTR modulators

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Vertex Pharmaceuticals (Europe) Limited
Date Filed
October 22, 2018
Date of Patent
August 11, 2020
Patent Applicant
‌
Vertex Pharmaceuticals (Europe) Limited
Patent Application Number
16166591
Patent Citations
‌
US Patent 10196384 Deuterated CFTR modulators
‌
US Patent 10239867 Modulators of ATP-binding cassette transporters
‌
US Patent 10206877 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
‌
US Patent 10022352 Modulators of ATP-binding cassette transporters
‌
US Patent 10047053 Deuterated CFTR potentiators
‌
US Patent 10058546 Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof
‌
US Patent 10071979 Process of producing cycloalkylcarboxamido-indole compounds
‌
US Patent 10081621 Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10738036
Patent Primary Examiner
‌
Samantha L Shterengarts

Find more entities like US Patent 10738036 Deuterated CFTR modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.